Expression of AID in malignant melanoma with BRAFV600E mutation

被引：0
|
作者：
Nakamura, M. [1 ]
Okura, R. [1 ]
Yoshioka, H. [1 ]
Yoshioka, M. [1 ]
Hiromasa, K. [1 ]
Nishio, D. [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Dept Dermatol, Kitakyushu, Fukuoka 807, Japan
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
AID; BRAF; melanoma;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TUE-100
引用
收藏
页码：465 / 465
页数：1
相关论文
共 50 条
  • [1] Expression of AID in malignant melanoma with BRAFV600E mutation
    Okura, Risa
    Yoshioka, Haruna
    Yoshioka, Manabu
    Hiromasa, Kana
    Nishio, Daisuke
    Nakamura, Motonobu
    [J]. EXPERIMENTAL DERMATOLOGY, 2014, 23 (05) : 347 - 348
  • [2] Modulation of MHC expression by BRAFV600E in melanoma
    Pollack, B. P.
    Sapkota, B.
    Hill, C. E.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S224 - S224
  • [3] Intrapatient Homogeneity of BRAFV600E Expression in Melanoma
    Menzies, Alexander M.
    Lum, Trina
    Wilmott, James S.
    Hyman, Jessica
    Kefford, Richard F.
    Thompson, John F.
    O'Toole, Sandra
    Long, Georgina V.
    Scolyer, Richard A.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (03) : 377 - 382
  • [4] Controversies in Intrapatient Melanoma BRAFV600E Mutation Status
    Riveiro-Falkenbach, Erica
    Santos-Briz, Angel
    Rios-Martin, Juan J.
    Rodriguez-Peralto, Jose L.
    [J]. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2017, 39 (04) : 291 - 295
  • [5] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    J S Wilmott
    A M Menzies
    L E Haydu
    D Capper
    M Preusser
    Y E Zhang
    J F Thompson
    R F Kefford
    A von Deimling
    R A Scolyer
    G V Long
    [J]. British Journal of Cancer, 2013, 108 : 924 - 931
  • [6] BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
    Wilmott, J. S.
    Menzies, A. M.
    Haydu, L. E.
    Capper, D.
    Preusser, M.
    Zhang, Y. E.
    Thompson, J. F.
    Kefford, R. F.
    von Deimling, A.
    Scolyer, R. A.
    Long, G. V.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (04) : 924 - 931
  • [7] Should BRAFV600E Be Tested in Primary or Metastatic Malignant Melanoma?
    Santos-Briz, A.
    Godoy, E.
    Arango, L.
    Antunez, P.
    Alcaraz, F.
    Fernandez, E.
    Ludena, M. D.
    [J]. MODERN PATHOLOGY, 2013, 26 : 120A - 120A
  • [8] Should BRAFV600E Be Tested in Primary or Metastatic Malignant Melanoma?
    Santos-Briz, A.
    Godoy, E.
    Arango, L.
    Antunez, P.
    Alcaraz, E.
    Fernandez, E.
    Ludena, M. D.
    [J]. LABORATORY INVESTIGATION, 2013, 93 : 120A - 120A
  • [9] cAMP signaling in BRAFV600E melanoma
    Rodriguez, Carlos I.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] A comparative study of Cobas® 4800 BRAFV600 mutation test and Immunohistochemistry anti-BRAFV600E for the detection of BRAFV600E mutation in melanoma samples
    Garcia Martin, R. M.
    Garrido Ruiz, M.
    Ruano, Y.
    Santos Briz, A.
    Rios Martin, J. J.
    Rodriguez Peralto, J. L.
    [J]. VIRCHOWS ARCHIV, 2015, 467 : S173 - S173
12345